Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study

AIMS: Although adjunctive cilostazol to dual antiplatelet therapy can reduce the risks of clinical events after percutaneous coronary intervention (PCI), whether genetic polymorphism can influence the pharmacodynamics of this regimen has not been evaluated. METHODS: One hundred and twenty-seven pati...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Kim, In-Suk, Jeong, Young-Hoon, Park, Yongwhi, Yoon, Seong-Eun, Kwon, Tae Jung, Park, Jeong Rang, Hwang, Seok-Jae, Koh, Eun-Ha, Kwak, Choong Hwan, Hwang, Jin-Yong, Kim, Sunjoo
Format: Artigo
Język:Inglês
Wydane: Blackwell Science Inc 2012
Hasła przedmiotowe:
Pharmacogenetics
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3376439/
https://ncbi.nlm.nih.gov/pubmed/22007612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.04131.x
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy